These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34736133)

  • 1. Synthesis and hyperglycemic, biochemical and histopathological evaluation of novel sulfonylbiguanide and sulfonylurea derivatives as potent anti-diabetic agents.
    Basyouni WM; Abbas SY; El-Bayouki KAM; Younis EA; Ali SA; Aly HF
    Bioorg Chem; 2021 Dec; 117():105418. PubMed ID: 34736133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, structural characterization and in vivo anti-diabetic evaluation of some new sulfonylurea derivatives in normal and silicate coated nanoparticle forms as anti-hyperglycemic agents.
    Sroor FM; Abbas SY; Basyouni WM; El-Bayouki KAM; El-Mansy MF; Aly HF; Ali SA; Arafa AF; Haroun AA
    Bioorg Chem; 2019 Nov; 92():103290. PubMed ID: 31561109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Biguanides as Anti-Diabetic Agents, Part II: Synthesis and Anti-Diabetic Properties Evaluation of 1-Arylamidebiguanide Derivatives as Agents of Insulin Resistant Type II Diabetes.
    Basyouni WM; Abbas SY; El Shehry MF; El-Bayouki KAM; Aly HF; Arafa A; Soliman MS
    Arch Pharm (Weinheim); 2017 Nov; 350(11):. PubMed ID: 29027251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Evaluation of 1-Substituted-Biguanide Derivatives as Anti-Diabetic Agents for Type II Diabetes Insulin Resistant.
    Abbas SY; Basyouni WM; El-Bayouki KA; Abdel-Rahman RF
    Drug Res (Stuttg); 2016 Jul; 66(7):377-83. PubMed ID: 27191826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Biguanides as Anti-Diabetic Agents Part I: Synthesis and Evaluation of 1-Substituted Biguanide Derivatives as Anti-Diabetic Agents of Type II Diabetes Insulin Resistant.
    Abbas SY; Basyouni WM; El-Bayouk KAM; Tohamy WM; Aly HF; Arafa A; Soliman MS
    Drug Res (Stuttg); 2017 Oct; 67(10):557-563. PubMed ID: 28651259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzenesulfonylurea derivatives.
    Rathish IG; Javed K; Bano S; Ahmad S; Alam MS; Pillai KK
    Eur J Med Chem; 2009 Jun; 44(6):2673-8. PubMed ID: 19171410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPARγ and SUR agonists.
    El-Zahabi MA; Elbendary ER; Bamanie FH; Radwan MF; Ghareib SA; Eissa IH
    Bioorg Chem; 2019 Oct; 91():103115. PubMed ID: 31310882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel sulfonyl(thio)urea derivatives act efficiently both as insulin secretagogues and as insulinomimetic compounds.
    Mascarello A; Frederico MJ; Castro AJ; Mendes CP; Dutra MF; Woehl VM; Yunes RA; Mena Barreto Silva FR; Nunes RJ
    Eur J Med Chem; 2014 Oct; 86():491-501. PubMed ID: 25203779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidiabetic effect of novel benzenesulfonylureas as PPAR-γ agonists and their anticancer effect.
    Kharbanda C; Alam MS; Hamid H; Javed K; Dhulap A; Bano S; Ali Y
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4601-5. PubMed ID: 26384286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and histopathological study of the anti-hyperglycemic and anti-hyperlipidemic effects of cornelian cherry (Cornus mas L.) in alloxan-induced diabetic rats.
    Asgary S; Rafieian-Kopaei M; Shamsi F; Najafi S; Sahebkar A
    J Complement Integr Med; 2014 Jun; 11(2):63-9. PubMed ID: 24710636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Docking, Synthesis and Biological Evaluation of Sulphonylureas/ Guanidine Derivatives as Promising Antidiabetic Agent.
    Panchal II; Sen DJ; Patel AD; Shah U; Patel M; Navale A; Bhavsar V
    Curr Drug Discov Technol; 2018; 15(4):315-325. PubMed ID: 28969569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of novel pyrroles and pyrrolopyrimidines as anti-hyperglycemic agents.
    Mohamed MS; Ali SA; Abdelaziz DH; Fathallah SS
    Biomed Res Int; 2014; 2014():249780. PubMed ID: 25054134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coumarin-chalcone hybrids targeting insulin receptor: Design, synthesis, anti-diabetic activity, and molecular docking.
    Konidala SK; Kotra V; Danduga RCSR; Kola PK
    Bioorg Chem; 2020 Nov; 104():104207. PubMed ID: 32947135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulinotropic action of 2, 4-dinitroanilino-benzoic acid through the attenuation of pancreatic beta-cell lesions in diabetic rats.
    Jahan H; Choudhary MI; Manzoor M; Khan KM; Perveen S; Atta-Ur-Rahman
    Chem Biol Interact; 2017 Aug; 273():237-244. PubMed ID: 28625491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The pharmacological blockade of protein glycosylation in diabetes mellitus using sulfonylurea derivatives and biguanides].
    Lebedeva EA
    Eksp Klin Farmakol; 1996; 59(5):40-2. PubMed ID: 9026209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral hypoglycemic agents.
    Ferner RE
    Med Clin North Am; 1988 Nov; 72(6):1323-35. PubMed ID: 3054355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Quinazoline-Sulfonylurea Conjugates: Design, Synthesis and Hypoglycemic Activity.
    Abou-Seri SM; Taha AM; Mohamed MA; Abdelkader NM
    Med Chem; 2019 Aug; 15(6):634-647. PubMed ID: 30526467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel hybrids of benzothiazole-1,3,4-oxadiazole-4-thiazolidinone: Synthesis, in silico ADME study, molecular docking and in vivo anti-diabetic assessment.
    Bhutani R; Pathak DP; Kapoor G; Husain A; Iqbal MA
    Bioorg Chem; 2019 Mar; 83():6-19. PubMed ID: 30339863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycemic, antilipidemic and antioxidant effects of valproic acid in alloxan-induced diabetic rats.
    Akindele AJ; Otuguor E; Singh D; Ota D; Benebo AS
    Eur J Pharmacol; 2015 Sep; 762():174-83. PubMed ID: 26015307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Evaluation of the Hypoglycemic and Hypolipidemic Activity of Sulfonamide-benzothiazole Derivatives of Benzylidene-2,4- thiazolidnedione.
    Ahmadi A; Khalili M; Sohrabi L; Delzendeh N; Nahri-Niknafs B; Ansari F
    Mini Rev Med Chem; 2017; 17(8):721-726. PubMed ID: 27903228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.